Advertisement
Screener

Infinity Pharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities, Continuing Operations

Infinity Pharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities, Continuing Operations

Infinity Pharmaceuticals, Inc. reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$36.71 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-15.

Discontinued › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2018-03-15

  • Infinity Pharmaceuticals, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-12-31 was $1.21M.
  • Infinity Pharmaceuticals, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-09-30 was -$11.04M.
  • Infinity Pharmaceuticals, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-06-30 was -$9.71M.
  • Infinity Pharmaceuticals, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-03-31 was -$17.18M.
  • Infinity Pharmaceuticals, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2017 was -$36.71M.
  • Infinity Pharmaceuticals, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2016 was -$154.36M.
  • Infinity Pharmaceuticals, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was -$83.65M, a 171.06% decline from fiscal 2014.
  • Infinity Pharmaceuticals, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2014 was $117.72M.
Period endNet Cash Provided by (Used in) Operating Activities, Continuing Operations 3 monthNet Cash Provided by (Used in) Operating Activities, Continuing Operations 6 monthNet Cash Provided by (Used in) Operating Activities, Continuing Operations 9 monthNet Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month
2017-12-31$1.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15
-$9.83M
derived: sum of 2 quarters · filed 2018-03-15
-$19.54M
derived: sum of 3 quarters · filed 2018-03-15
-$36.71M
10-K · filed 2018-03-15
2017-09-30-$11.04M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
-$20.74M
derived: sum of 2 quarters · filed 2017-11-07
-$37.92M
10-Q · filed 2017-11-07
-$58.89M
derived: sum of 4 quarters · filed 2018-03-15
2017-06-30-$9.71M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03
-$26.88M
10-Q · filed 2017-08-03
-$47.85M
derived: sum of 3 quarters · filed 2018-03-15
-$82.94M
derived: sum of 4 quarters · filed 2018-03-15
2017-03-31-$17.18M
10-Q · filed 2017-05-09
-$38.14M
derived: sum of 2 quarters · filed 2018-03-15
-$73.23M
derived: sum of 3 quarters · filed 2018-03-15
-$119.66M
derived: sum of 4 quarters · filed 2018-03-15
2016-12-31-$20.97M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15
-$56.06M
derived: sum of 2 quarters · filed 2018-03-15
-$102.48M
derived: sum of 3 quarters · filed 2018-03-15
-$154.36M
10-K · filed 2018-03-15
2016-09-30-$35.09M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
-$81.52M
derived: sum of 2 quarters · filed 2017-11-07
-$133.39M
10-Q · filed 2017-11-07
-$50.62M
derived: sum of 4 quarters · filed 2018-03-15
2016-06-30-$46.43M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03
-$98.30M
10-Q · filed 2017-08-03
-$15.53M
derived: sum of 3 quarters · filed 2018-03-15
-$50.45M
derived: sum of 4 quarters · filed 2018-03-15
2016-03-31-$51.87M
10-Q · filed 2017-05-09
$30.89M
derived: sum of 2 quarters · filed 2018-03-15
-$4.02M
derived: sum of 3 quarters · filed 2018-03-15
-$35.87M
derived: sum of 4 quarters · filed 2018-03-15
2015-12-31$82.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15
$47.85M
derived: sum of 2 quarters · filed 2018-03-15
$16.00M
derived: sum of 3 quarters · filed 2018-03-15
-$83.65M
10-K · filed 2018-03-15
2015-09-30-$34.92M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
-$66.76M
derived: sum of 2 quarters · filed 2016-11-09
-$166.42M
10-Q · filed 2016-11-09
-$213.40M
derived: sum of 4 quarters · filed 2017-03-14
2015-06-30-$31.84M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
-$131.50M
10-Q · filed 2016-08-09
-$178.48M
derived: sum of 3 quarters · filed 2017-03-14
$59.76M
derived: sum of 4 quarters · filed 2017-03-14
2015-03-31-$99.66M
10-Q · filed 2016-05-04
-$146.64M
derived: sum of 2 quarters · filed 2017-03-14
$91.60M
derived: sum of 3 quarters · filed 2017-03-14
$61.61M
derived: sum of 4 quarters · filed 2017-03-14
2014-12-31-$46.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14
$191.26M
derived: sum of 2 quarters · filed 2017-03-14
$161.27M
derived: sum of 3 quarters · filed 2017-03-14
$117.72M
10-K · filed 2017-03-14
2014-09-30$238.24M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
$208.25M
derived: sum of 2 quarters · filed 2015-11-05
$164.69M
10-Q · filed 2015-11-05
$128.23M
derived: sum of 4 quarters · filed 2016-02-23
2014-06-30-$29.99M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
-$73.54M
10-Q · filed 2015-08-06
-$110.01M
derived: sum of 3 quarters · filed 2016-02-23
-$136.40M
derived: sum of 4 quarters · filed 2016-02-23
2014-03-31-$43.55M
10-Q · filed 2015-05-06
-$80.02M
derived: sum of 2 quarters · filed 2016-02-23
-$106.42M
derived: sum of 3 quarters · filed 2016-02-23
-$132.16M
derived: sum of 4 quarters · filed 2016-02-23
2013-12-31-$36.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23
-$62.86M
derived: sum of 2 quarters · filed 2016-02-23
-$88.61M
derived: sum of 3 quarters · filed 2016-02-23
-$113.91M
10-K · filed 2016-02-23
2013-09-30-$26.39M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
-$52.14M
derived: sum of 2 quarters · filed 2014-11-10
-$77.44M
10-Q · filed 2014-11-10
2013-06-30-$25.75M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11
-$51.05M
10-Q · filed 2014-08-11
2013-03-31-$25.30M
10-Q · filed 2014-05-06
2012-12-31-$80.14M
10-K · filed 2015-02-24